Geneesmiddelenbeleid

This procedure involves a hearing or roundtable discussion regarding the national medicines policy in the Netherlands. It focuses on how the government manages the availability, pricing, and distribution of pharmaceutical products to ensure public health and sustainable healthcare spending. The outcomes affect healthcare providers, pharmaceutical companies, and patients by potentially influencing how medicines are procured and reimbursed within the Dutch health system.